Enterprise Products Partners LP
Change company Symbol lookup
Select an option...
EPD Enterprise Products Partners LP
STLB Sterling Business Solutions Inc
CITY Avalon Correctional Services Inc
TEVJF Teva Pharmaceutical Industries Ltd
UMBF UMB Financial Corp
OXM Oxford Industries Inc
ICON Iconix Brand Group Inc
BAC Bank of America Corp
ON ON Semiconductor Corp
EQNR Equinor ASA

Energy : Oil, Gas & Consumable Fuels | Large Cap Value
Company profile

Enterprise Products Partners L.P. (Enterprise) is a provider of midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals and refined products in North America. The Company's segments include NGL Pipelines & Services; Crude Oil Pipelines & Services; Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services. The Company's midstream energy operations include natural gas gathering, treating, processing, transportation and storage; NGL transportation, fractionation, storage, and import and export terminals, including liquefied petroleum gas (LPG); crude oil gathering, transportation, storage and terminals; petrochemical and refined products transportation, storage, export and import terminals, and related services, and a marine transportation business that operates primarily on the United States inland and Intracoastal Waterway systems.

Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

Today's volume of 20,687 shares is on pace to be much lighter than EPD's 10-day average volume of 8,582,371 shares.


Global Coronary Stents Market (2020 to 2027) - Featuring Abbott, Medtronic & Boston Scientific Corporation Among Others - ResearchAndMarkets.com

7:09 am ET April 9, 2020 (BusinessWire) Print

The "Coronary Stents Market Size, Share & Trends Analysis Report by Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), by Region (North America, Europe, APAC, Latin America, MEA), and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

The global coronary stents market size is expected to reach USD 11.3 billion by 2027, expanding at a CAGR of 4.7%. Increasing adoption of minimally invasive surgeries and percutaneous coronary intervention (PIC) procedures is expected to drive the market for coronary stents in the coming years. Moreover, increasing geriatric population is considered as a high impact rendering driver for the growth of this industry over the forecast period. Technological advancement in 2nd generation drug eluting stents (DES) is further fueling the growth. Development of biodegradable and polymer free DES in order to increase patient compliance is expected to drive the market over the coming years.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare and Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service provider. From January 2020, Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in ambulatory surgical center (ASC), which is expected to boost market revenue over the forecast period.

Companies Mentioned

Abbott Medtronic Boston Scientific Corporation Terumo Corporation B Braun Melsungen AG Biotronik Stentys SA MicroPort Scientific Corporation C. R. Bard, Inc. Cook Medical

Further key findings from the report suggest:

In terms of revenue, the DES dominated the product segment as of 2019. New product launches and technological advancements in 2nd gen DES are acting as the driving factor for this segment Prices for the first-generation BVS (Bioresorbable Vascular Scaffold) are much high as compared to existing BMS (Bare Metal Stent) and DES. Due to its safety concern and high hospitalization rates, doctors are not preferring BRS over DES. Moreover, high crossing profile and bulky struts are factors majorly impeding the BRS market Asia Pacific is expected to exhibit the highest growth rate over the forecast period. Increase in disposable income and growing incidence of heart diseases will fuel market growth in the coming years Some of the key companies present in the coronary stent market are Medtronic, Abbott, Boston Scientific, Terumo Corporation, Biotronik, and Microport Corporation With USD 2.3 billion R&D expenditure in 2018, Abbott is anticipated to provide with technologically advanced second generation DES and may be BVS in near future.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Industry Outlook

3.1 Market Segmentation

3.2 Market Lineage Outlook

3.2.1 Parent Market Analysis

3.2.2 Ancillary Market Analysis

3.3 Market Variable Analysis

3.3.1 Market Driver Analysis Rising burden of Cardiovascular Diseases (CVDs) Government initiatives to reduce the cost of coronary stents Advancements in stenting technologies

3.3.2 Market Restraint Analysis Stringent regulation and approval Product recall and failure

3.3.3 Industry Challenges Risk associated with coronary stent post-procedure

3.4 Penetration & Growth Prospect Mapping

3.5 User Perspective Analysis

3.5.1 Consumer Behavior Analysis

3.5.2 Market Influencer Analysis

3.6 Pricing Analysis

3.7 Technology Overview

3.8 Regulatory Framework

3.8.1 Regulatory Landscape

3.8.2 Reimbursement Framework CPT Coding implications HCPCS Coding implications

3.8.3 Cms New Reimbursement Policy For Pci

3.9 Product Pipeline/Clinical Trial Analysis

3.10 R&D Expenditure Analysis

3.11 Estimated R&D Expenditure On Various Types Of Stents (2014 - 2019)

3.12 Product Recalls

3.13 Business Environment Analysis tools

3.13.1 Swot Analysis, By Pest

3.13.2 Porter's Five Forces Analysis

4. Coronary Stents Market: Competitive Analysis

4.1 Market Participation Categorization

4.2 Competitive Dashboard Analysis

4.3 Innovators

4.4 Recent Innovations

4.5 Public Companies

4.5.1 Company Market Share Analysis

4.5.2 Company Market Position Analysis

4.5.3 Heat Map Analysis

4.6 Vendor Landscape

4.6.1 List Of Coronary Stent Providers

5. Product Segment Analysis

5.1 Coronary Stents Market: Product Movement Analysis

5.2 Bare Metal Stents

5.2.1 Bare Metal Stents Market, 2016 - 2027 (USD Million)

5.3 Drug Eluting Stents

5.3.1 Drug Eluting Stents Market, 2016 - 2027 (USD Million)

5.3.2 Biodegradable Drug Eluting Stents

5.3.3 Non-Biodegradable Drug Eluting Stents

5.4 Bioresorbable Vascular Scaffolds

6. Coronary Stents Market: Regional Estimates & Trend Analysis, by Product

6.1 Coronary Stents Market Share by Region, 2019 & 2027

6.2 North America

6.3 Europe

6.4 Asia Pacific

6.5 Latin America

6.6 MEA

7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/lzxsrw

View source version on businesswire.com: https://www.businesswire.com/news/home/20200409005383/en/

SOURCE: Research and Markets

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.